Co-engagement of TIGIT+ immune cells to PD-L1+ tumours by a bispecific antibody potentiates T-cell response and tumour control https://www.biorxiv.org/content/10.1101/2023.05.11.540461v1?med=mas
Co-engagement of TIGIT+ immune cells to PD-L1+ tumours by a bispecific antibody potentiates T-cell response and tumour control https://www.biorxiv.org/content/10.1101/2023.05.11.540461v1?med=mas